Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Due Buron

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Neurology|July 9, 2020
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort studyMathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg, et al.
Sensors (Basel, Switzerland)|July 14, 2023
Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple SclerosisSpyridon Kontaxis, Estela Laporta, Esther Garcia, et al.
Frontiers in Physiology|April 24, 2023
Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosisSpyridon Kontaxis, Estela Laporta, Esther Garcia, et al.
Journal of Clinical Medicine|December 11, 2022
Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple SclerosisSara Siddi, Iago Giné-Vázquez, Raquel Bailon, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neurology|July 9, 2020
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort studyMathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg, et al.
Sensors (Basel, Switzerland)|July 14, 2023
Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple SclerosisSpyridon Kontaxis, Estela Laporta, Esther Garcia, et al.
Frontiers in Physiology|April 24, 2023
Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosisSpyridon Kontaxis, Estela Laporta, Esther Garcia, et al.
Journal of Clinical Medicine|December 11, 2022
Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple SclerosisSara Siddi, Iago Giné-Vázquez, Raquel Bailon, et al.
Pageof 2